It comprises five targets that include: 80% of people with diabetes are diagnosed, 80% of people have reasonable glycemic control, 80% of diagnosed people have good blood pressure control, 60% of people with diabetes over 40 years receive statins, and 100% of people with type 1 diabetes have access to affordable insulin and blood glucose self‐monitoring. This evidence concerns the gene INS and diabetes mellitus.